The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(4-(2-(4-(4-(2-Oxopyrrolidin-1-yl)phenyl)piperidin-1-yl)ethyl)-1H-pyrazol-1-yl)pyrido[3,4-d]pyrimidin-4(3H)-one ID: ALA4522584
PubChem CID: 155543678
Max Phase: Preclinical
Molecular Formula: C27H29N7O2
Molecular Weight: 483.58
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1CCCN1c1ccc(C2CCN(CCc3cnn(-c4nccc5c(=O)[nH]cnc45)c3)CC2)cc1
Standard InChI: InChI=1S/C27H29N7O2/c35-24-2-1-12-33(24)22-5-3-20(4-6-22)21-9-14-32(15-10-21)13-8-19-16-31-34(17-19)26-25-23(7-11-28-26)27(36)30-18-29-25/h3-7,11,16-18,21H,1-2,8-10,12-15H2,(H,29,30,36)
Standard InChI Key: OTYMAMBJVVRSCZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
22.9749 -16.8060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9737 -17.6256 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6818 -18.0345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6800 -16.3972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3886 -16.8024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3894 -17.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0979 -18.0285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8061 -17.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8014 -16.7956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0923 -16.3922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6842 -18.8493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0242 -19.3312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2785 -20.1078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0958 -20.1059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3464 -19.3281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0880 -15.5750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5777 -20.7659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3902 -20.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8721 -21.3385 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5370 -22.0840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0153 -22.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8286 -22.6590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1613 -21.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6808 -21.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3055 -23.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9704 -24.0640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4491 -24.7254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2628 -24.6415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5956 -23.8905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1148 -23.2322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7463 -25.3023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4938 -26.0795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1549 -26.5599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8161 -26.0796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5635 -25.3024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0438 -24.6413 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 5 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
3 11 1 0
10 16 2 0
14 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
22 25 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 31 1 0
28 31 1 0
35 36 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 483.58Molecular Weight (Monoisotopic): 483.2383AlogP: 3.05#Rotatable Bonds: 6Polar Surface Area: 100.01Molecular Species: BASEHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.07CX Basic pKa: 9.04CX LogP: 1.72CX LogD: 0.32Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.45Np Likeness Score: -1.39
References 1. Le Bihan YV, Lanigan RM, Atrash B, McLaughlin MG, Velupillai S, Malcolm AG, England KS, Ruda GF, Mok NY, Tumber A, Tomlin K, Saville H, Shehu E, McAndrew C, Carmichael L, Bennett JM, Jeganathan F, Eve P, Donovan A, Hayes A, Wood F, Raynaud FI, Fedorov O, Brennan PE, Burke R, van Montfort RLM, Rossanese OW, Blagg J, Bavetsias V.. (2019) C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays., 177 [PMID:31158747 ] [10.1016/j.ejmech.2019.05.041 ]